Nuvalent elects Emily Conley to Board of Directors

Nuvalent, Inc.

Emily Conley elected as Class III director effective Feb 2, 2022, serving until 2024 annual meeting.
Board determined Conley is independent under Nasdaq rules; no committee appointments yet.
Received initial option grant for 40,000 shares at $13.79/share, vesting equally over 3 years.
Conley will receive standard non-employee director compensation including cash retainers and annual equity.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Emily Conley

Director

NUVL · Nuvalent, Inc.

Effective: 2022-02-02
Filed: February 3, 2022, 6:59 PM ET

the Board elected Emily Conley as a member of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Emily Conley was elected as Director at Nuvalent, Inc..

Action: elected
Role: Director

Exact text from the filing

the Board elected Emily Conley as a member of the Board, effective immediately.

View on SEC.gov

Nuvalent, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-026373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.